Text version
Hi! David Rosenberg here for the Psychopharmacology Institute. In this CAP—or Child and Adolescent Psychiatry—Smart Take, we will closely examine the pharmacogenomic profiling of pediatric patients on psychotropic medications presenting in an emergency department in an acute behavioral crisis. This is such a highly complex area, but it is fascinating. I believe this is where the field is going and needs to go. We are not there yet, but this has the chance to be a game changer and to advance our ability to more effectively prescribe, monitor, and treat pediatric patients with childhood-onset neuropsychiatric disorders. This type of work has the potential to guide individualized and personalized medication choices and enhance the likelihood of good therapeutic response, tolerability, and decreased side effects. Pharmacogenomic testing is becoming increasingly common in guiding medication side effects. Some facilities are routinely getting this testing for adult patients. It is increasingly being recognized that
Unlock this CAP Smart Take and earn 0.50 CMEs
Become a Silver, Gold, Silver extended, Gold extended, Gold – fr, Silver – fr, Silver extended – fr or Gold extended – fr Member.
Already have an account? Sign in
